TG THERAPEUTICS INC. - COMMON STOCK
16.92
10-五月-24 09:45:05
15 分钟延时
股票
-0.01
-0.03%
今日范围
16.86 - 17.13
ISIN
N/A
来源
NASDAQ
-
26 1月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
TG Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
06 1月 2023 06:30:00 条件 Nasdaq GlobeNewswire
-
TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy)
28 12月 2022 12:48:07 条件 Nasdaq GlobeNewswire
-
TG Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
10 11月 2022 06:30:01 条件 Nasdaq GlobeNewswire
-
TG Therapeutics to Host Conference Call on Third Quarter 2022 Financial Results and Business Update
08 11月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
TG Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
09 9月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
25 8月 2022 06:30:47 条件 Nasdaq GlobeNewswire
-
TG Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
08 8月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
TG Therapeutics to Host Conference Call on Second Quarter 2022 Financial Results and Business Update
05 8月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
TG Therapeutics Announces FDA Extension of BLA PDUFA Date for Ublituximab to Treat Patients with RMS
31 5月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
TG Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
20 5月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
26 4月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
15 4月 2022 07:30:00 条件 Nasdaq GlobeNewswire